Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.
Lewis DJ, Haun PL, Samimi SS, Vittorio CC, Villasenor-Park J, Barta SK, Landsburg DJ, Svoboda J, Nasta SD, Schuster SJ, Rook AH, Kim EJ.
Lewis DJ, et al. Among authors: vittorio cc.
JAMA Dermatol. 2021 Mar 1;157(3):317-321. doi: 10.1001/jamadermatol.2020.4901.
JAMA Dermatol. 2021.
PMID: 33377934
Free PMC article.